Effect of an anti-human Co-029/tspan8 mouse monoclonal antibody on tumor growth in a nude mouse model
Open Access
- 19 September 2014
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Physiology
- Vol. 5, 364
- https://doi.org/10.3389/fphys.2014.00364
Abstract
New therapeutic agents are needed in digestive tract tumours. Co-029/tspan8 is a tetraspanin frequently expressed on human colorectal tumours, In this work, we report the effects of the monoclonal antibody Ts29.2, targeting Co-029/tspan8, on colorectal tumor cells in vitro and after implantation in nude mice. HT29, Isreco1 and SW480 colorectal tumor cell lines were used for this study. HT29 has a strong endogenous expression of Co-029/tspan8, whereas Isreco1 cells don’t express Co-029/tspan8 and SW480 has only a weak expression. Isreco1 and SW480 were transduced to express Co-029/tspan8 at the same level as HT29. In order to check the specificity of the effect of monoclonal antibody Ts29.2, low Co029/tspan8 expressing SW480 cells were injected simultaneously with transduced cells in the back, on the left and right sides of the mice. With an early treatment, Ts29.2 mAb inhibited growth of tumors expressing Co-029/tspan8 up to 70%, whereas a delayed treatment was less efficient. No effect of the antibody on cell proliferation or apoptosis induction was detected in vitro. No increase of activated caspase 3 labeling was observed in vivo and areas occupied by vessels were not significantly different between treated mice and controls. This suggests that the action of Ts29.2 is linked neither to cellular toxicity nor to the inhibition of the previously reported angiogenic properties of Co-029/tspan8. An inhibition of cell proliferation in vivo is demonstrated by a reduction of the mitotic index in HT29 tumors of Ts29.2 treated mice. The discrepancy between in vitro and in vivo data on cell proliferation suggests that the binding of Ts29.2 to tumour cells may modify their response to signals issued from the microenvironment. Given the restricted pattern of tissue expression of the tetraspanin Co-029/tspan8, these preliminary results put forth for consideration the antibody targeting of this tetraspanin in further investigations for therapeutic applications.Keywords
This publication has 43 references indexed in Scilit:
- Knockout of the tetraspaninCd9in the TRAMP model ofde novoprostate cancer increases spontaneous metastases in an organ-specific mannerInternational Journal of Cancer, 2013
- Genetic Ablation of the Tetraspanin CD151 Reduces Spontaneous Metastatic Spread of Prostate Cancer in the TRAMP ModelMolecular Cancer Research, 2013
- Lateral organization of membrane proteins: tetraspanins spin their webBiochemical Journal, 2009
- Prognostic Variables for Resection of Colorectal Cancer Hepatic Metastases: An Evolving ParadigmJournal of Clinical Oncology, 2008
- TetraspaninsCellular and Molecular Life Sciences, 2001
- Tetraspanins and malignancyExpert Reviews in Molecular Medicine, 2001
- Association Between the Rat Homologue of CO-029, a Metastasis-associated Tetraspanin Molecule and Consumption CoagulopathyThe Journal of cell biology, 1998
- Differential display cloning identifies motility-related protein (MRP1/CD9) as highly expressed in primary compared to metastatic human colon carcinoma cells.1997
- Human large granular lymphocytes express high affinity receptors for murine monoclonal antibodies of the IgG3 subclass.The Journal of Immunology, 1987
- Tumors undergoing rejection induced by monoclonal antibodies of the IgG2a isotype contain increased numbers of macrophages activated for a distinctive form of antibody-dependent cytolysis.Proceedings of the National Academy of Sciences of the United States of America, 1984